Comparison of SARS-CoV-2 antibody responses following the second dose of BNT162b2 and mRNA-1273 vaccines in people living with HIV-1. Murata M, Matsumoto Y, Shimono N. Vaccine 2025;62:127457.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Murata M, Matsumoto Y, Shimono N. Comparison of SARS-CoV-2 antibody responses following the second dose of BNT162b2 and mRNA-1273 vaccines in people living with HIV-1. Vaccine 2025;62:127457.
PMID: 40645029